Plasmonic coffee-ring biosensing for AI-assisted point-of-care diagnostics.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 40382337.
- Also identified by DOI 10.1038/s41467-025-59868-y and PMC identifier 12085679.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A major challenge in addressing global health issues is developing simple, affordable biosensors with high sensitivity and specificity. Significant progress has been made in at-home medical detection kits, especially during the COVID-19 pandemic. Here, we demonstrated a coffee-ring biosensor with ultrahigh sensitivity, utilizing the evaporation of two sessile droplets and the formation of coffee-rings with asymmetric nanoplasmonic patterns to detect disease-relevant proteins as low as 3 pg/ml, under 12 min. Experimentally, a protein-laden droplet dries on a nanofibrous membrane, pre-concentrating biomarkers at the coffee ring. A second plasmonic droplet with functionalized gold nanoshells is then deposited at an overlapping spot and dried, forming a visible asymmetric plasmonic pattern due to distinct aggregation mechanisms. To enhance detection sensitivity, a deep neural model integrating generative and convolutional networks was used to enable quantitative biomarker diagnosis from smartphone photos. We tested four different proteins, Procalcitonin (PCT) for sepsis, SARS-CoV-2 Nucleocapsid (N) protein for COVID-19, Carcinoembryonic antigen (CEA) and Prostate-specific antigen (PSA) for cancer diagnosis, showing a working concentration range over five orders of magnitude. Sensitivities surpass equivalent lateral flow immunoassays by over two orders of magnitude using human saliva samples. The detection principle, along with the device, and materials can be further advanced for early disease diagnostics.
Medical subject headings
- COVID-19
- Biosensing Techniques
- Point-of-Care Systems